Skip to main content
. 2022 Mar 15;66(3):e01793-21. doi: 10.1128/aac.01793-21

TABLE 4.

Treatment-specific fixed-effects parameter estimates

Regimena INTTRT
SLPTRT
Estimate SE Estimate SE
BPa 2.270 1.110 −1.96 0.892
BPaL 0.499 0.780 −3.77 0.782
HE 21.50 2.420 −3.00 0.270
HRE or HRE/HR 9.580 0.998 −3.00 0.270
HRZ/HR 4.860 0.481 −3.00 0.270
HRZE or HRZE/HRZ 4.700 0.438 −3.23 0.317
HRZE/HR 4.700 0.438 −3.00 0.270
HRZM 3.610 0.759 −4.79 1.260
HRZM/HRM 3.610 0.759 −3.00 0.270
HZE 12.70 1.330 −3.00 0.270
RMZ/RM_BIDMb 0.654 1.160 −3.11 0.492
RMZ 2.220 0.885 −3.54 0.787
RMZ/RM 2.220 0.885 −3.11 0.492
RMZE 2.110 0.771 −3.54 0.787
RMZE/RM 2.110 0.771 −3.11 0.492
a

B, bedaquiline; E, ethambutol; H, isoniazid; L, linezolid; M, moxifloxacin; Pa, pretomanid; R, rifampin; Z, pyrazinamide.

b

Moxifloxacin 100 mg/kg dosed twice daily for a total daily dose of 200 mg/kg.